|
Apr 24
|
Merck: Q1 Earnings Snapshot
|
|
Apr 24
|
Merck Announces First-Quarter 2025 Financial Results
|
|
Apr 23
|
Alphabet earnings, Fed comments, Nintendo Switch 2: What to Watch
|
|
Apr 23
|
BioNTech Surges On Summit's Coattails. But Can They Take On Merck?
|
|
Mar 21
|
3 of Goldman Sachs' best investing tips for currently volatile markets
|
|
Mar 20
|
Merck (NYSE:MRK) Unveils New Data On Cardiovascular Advances At ACC.25 Annual Conference
|
|
Mar 20
|
Merck & Co., Inc. (MRK): Among Incredibly Cheap Dividend Stock to Buy Now
|
|
Mar 19
|
Why Merck & Co. (MRK) Is Among the Most Undervalued Biotech Stocks to Invest In
|
|
Mar 19
|
Merck Loses Almost $52B in 6 Months: How to Play MRK Stock
|
|
Mar 19
|
Actinium Pharmaceuticals launches clinical trial for Actimab-A in combination
|
|
Mar 19
|
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy
|
|
Mar 19
|
Merck Data at ACC.25 Highlight Innovative Advancements and Commitment to Improving Outcomes for People Living with Cardiovascular Disease
|
|
Mar 18
|
Is Merck & Co Inc. (NYSE:MRK) the Most Undervalued S&P 500 Stock to Buy Now?
|
|
Mar 17
|
Is Merck & Co Inc. (NYSE:MRK) the Most Profitable Value Stock to Buy Now?
|
|
Mar 16
|
Merck & Co., Inc. (MRK): Among Top Dividend Contenders List
|
|
Feb 17
|
Is Merck & Co., Inc. (MRK) the Most Oversold S&P 500 Stock in 2024?
|
|
Feb 15
|
Jim Cramer Comments on Merck & Co., Inc. (MRK) and Its China Woes
|
|
Feb 13
|
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know
|
|
Feb 13
|
Merck & Co., Inc. (MRK): A Bull Case Theory
|
|
Feb 13
|
US pharma giant Merck backs healthcare marketplace HD in Southeast Asia
|